Comparative responsiveness of Parkinson's disease scales to change over time
- 6 February 2009
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 24 (6), 813-818
- https://doi.org/10.1002/mds.22438
Abstract
The objective of the study is to examine the comparative responsiveness of outcome measures to assess progression over time in Parkinson's disease (PD). One hundred twenty‐eight patients participating in a clinic‐based naturalistic study of PD were assessed with the Hoehn and Yahr, UPDRS, MMSE, PDQ‐39, PDQL, EQ‐5D, and BDI scales at baseline and at 1 year. In addition, 82 patients in a community‐based study of patients with PD who had completed self‐rated Schwab and England, PDQ‐39, EQ‐5D, and BDI scales at baseline, were sent the same questionnaires at 1 and 4 years. Responsiveness was assessed using t‐tests, standardised effect size, and standardised response mean. In both samples, the Hr‐QoL measures were less responsive to change over time than the impairment and disability scales (Hoehn and Yahr, UPDRS, Schwab and England scales). In addition, in the clinic‐based sample, Hoehn and Yahr and UPDRS ADL scale (“on”) were more responsive to progression over time than UPDRS motor part and ADL part (“off”). Hr‐QoL measures are less responsive to change over time than measures of impairment and disability. Although this suggests that these measures are less accurate in detecting subtle changes, it may also indicate that the multifactorial subjective assessment of Hr‐QoL adapts to changes over time. Global assessment of overall impairment and disability (which incorporates motor and nonmotor features of PD), however, appeared relatively responsive to change over time in patients in a naturalistic setting. © 2009 Movement Disorder SocietyKeywords
This publication has 22 references indexed in Scilit:
- Longitudinal psychometric attributes, responsiveness, and importance of change: An approach using the SCOPA‐Psychosocial questionnaireMovement Disorders, 2008
- Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuationsActa Neurologica Scandinavica, 2005
- Cost of Illness and its Predictors for Parkinson??s Disease in GermanyPharmacoEconomics, 2005
- Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuationsMovement Disorders, 2001
- Methods for assessing responsivenessJournal of Clinical Epidemiology, 2000
- Quality of life in patients with Parkinson's disease: development of a questionnaire.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- ParkinsonismNeurology, 1967